Benitec Biopharma Balance Sheet Health
Financial Health criteria checks 3/6
Benitec Biopharma has a total shareholder equity of $202.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.5M and $4.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$2.48m |
Equity | US$202.00k |
Total liabilities | US$4.26m |
Total assets | US$4.46m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BJ9's short term assets ($3.7M) do not cover its short term liabilities ($4.0M).
Long Term Liabilities: BJ9's short term assets ($3.7M) exceed its long term liabilities ($284.0K).
Debt to Equity History and Analysis
Debt Level: BJ9 is debt free.
Reducing Debt: BJ9 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BJ9 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BJ9 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.9% each year